What is Lapovations?
Lapovations specializes in creating advanced technologies designed to improve the reliability and reduce the invasiveness of laparoscopic surgical procedures. Their core focus is on addressing critical challenges within these operations, particularly concerning abdominal entry. The company's flagship product, AbGrab, offers a clinically tailored solution for abdominal wall elevation, aiming to bolster patient safety and surgical success rates. Lapovations targets healthcare professionals and surgical teams seeking cutting-edge tools to refine their minimally invasive surgery practices.
How much funding has Lapovations raised?
Lapovations has raised a total of $1.3M across 2 funding rounds:
Debt
$24K
Series A
$1.3M
Debt (2021): $24K with participation from PPP
Series A (2023): $1.3M, investors not publicly disclosed
What's next for Lapovations?
The recent major strategic investment signifies Lapovations' transition into a scaling phase, likely focusing on expanding market reach and further developing its product pipeline. This capital infusion is expected to accelerate the adoption of AbGrab and support research into next-generation surgical innovations. The company's strategic direction will likely involve strengthening partnerships within the healthcare ecosystem and enhancing its commercial operations to meet growing demand for advanced laparoscopic solutions.
See full Lapovations company page
